Technical Analysis for MTEM - Molecular Templates, Inc.

Grade Last Price % Change Price Change
F 2.07 -24.73% -0.68
MTEM closed down 24.73 percent on Monday, March 18, 2024, on 6.94 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 28
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Down 2 ATRs about 9 hours ago
60 Minute Opening Range Breakdown about 13 hours ago
2x Volume Pace about 14 hours ago
1.5x Volume Pace about 14 hours ago
3x Volume Pace about 14 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is headquartered in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Solid Tumors Treatment Of Cancer Cancer Treatment Oncology Chemical Elements Lymphoma Oxygen Toxins Prodrugs Evofosfamide Prodrug Nitrogen Mustards

Is MTEM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.45
52 Week Low 2.0
Average Volume 10,362
200-Day Moving Average 5.87
50-Day Moving Average 3.57
20-Day Moving Average 3.49
10-Day Moving Average 3.06
Average True Range 0.33
RSI (14) 20.63
ADX 32.72
+DI 7.64
-DI 41.10
Chandelier Exit (Long, 3 ATRs) 3.12
Chandelier Exit (Short, 3 ATRs) 3.00
Upper Bollinger Bands 4.61
Lower Bollinger Band 2.37
Percent B (%b) -0.14
BandWidth 64.05
MACD Line -0.32
MACD Signal Line -0.16
MACD Histogram -0.1537
Fundamentals Value
Market Cap 11.12 Million
Num Shares 5.37 Million
EPS -6.92
Price-to-Earnings (P/E) Ratio -0.30
Price-to-Sales 0.36
Price-to-Book 2.77
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.21
Resistance 3 (R3) 3.31 3.04 3.02
Resistance 2 (R2) 3.04 2.75 2.99 2.96
Resistance 1 (R1) 2.55 2.57 2.42 2.45 2.89
Pivot Point 2.28 2.28 2.21 2.23 2.28
Support 1 (S1) 1.79 1.99 1.66 1.69 1.25
Support 2 (S2) 1.52 1.81 1.47 1.18
Support 3 (S3) 1.03 1.52 1.12
Support 4 (S4) 0.93